1.
Nahmias ZP, Merrill ED, Briscoe CC, Mount CE, Abner S, Schaffer A, Anadkat MJ. Development of Bullous Pemphigoid While Receiving PD-1 Checkpoint Inhibitor Nivolumab. J of Skin [Internet]. 2018 Apr. 30 [cited 2024 Jul. 24];2(3):175-80. Available from: https://jofskin.org/33014/index.php/skin/article/view/322